Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Lorazepam

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 974Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Orion Corporation

    02 3AA PHARMA INC

    03 3APOTEX INC

    04 2PFIZER CANADA ULC

    05 3PHARMASCIENCE INC

    06 3PRO DOC LIMITEE

    07 3Pharmascience Inc.

    08 1SANDOZ CANADA INCORPORATED

    09 3TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Orion Corporation

    Finland
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : Canada

    Lorazepam

    Brand Name :

    Dosage Form : TABLET

    Dosage Strength : 1MG

    Packaging :

    Approval Date :

    Application Number : 71087

    Regulatory Info : Generic

    Registration Country : Canada

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AA PHARMA INC

    U.S.A
    ASPEN
    Not Confirmed
    arrow

    AA PHARMA INC

    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : LORAZEPAM SUBLINGUAL

    Dosage Form : TABLET

    Dosage Strength : 0.5MG

    Packaging : 100/500

    Approval Date :

    Application Number : 2410745

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AA PHARMA INC

    U.S.A
    ASPEN
    Not Confirmed
    arrow

    AA PHARMA INC

    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : LORAZEPAM SUBLINGUAL

    Dosage Form : TABLET

    Dosage Strength : 1MG

    Packaging : 100/500

    Approval Date :

    Application Number : 2410753

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    AA PHARMA INC

    U.S.A
    ASPEN
    Not Confirmed
    arrow

    AA PHARMA INC

    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : LORAZEPAM SUBLINGUAL

    Dosage Form : TABLET

    Dosage Strength : 2MG

    Packaging : 100/500

    Approval Date :

    Application Number : 2410761

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    APOTEX INC

    Canada
    ASPEN
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : APO-LORAZEPAM

    Dosage Form : TABLET

    Dosage Strength : 0.5MG

    Packaging : 100/500

    Approval Date :

    Application Number : 655740

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    APOTEX INC

    Canada
    ASPEN
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : APO-LORAZEPAM

    Dosage Form : TABLET

    Dosage Strength : 1MG

    Packaging : 100/1000/3000

    Approval Date :

    Application Number : 655759

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    APOTEX INC

    Canada
    ASPEN
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : APO-LORAZEPAM

    Dosage Form : TABLET

    Dosage Strength : 2MG

    Packaging : 100/1000/3000

    Approval Date :

    Application Number : 655767

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    PFIZER CANADA ULC

    U.S.A
    ASPEN
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : ATIVAN

    Dosage Form : TABLET

    Dosage Strength : 1MG

    Packaging : 100

    Approval Date :

    Application Number : 2041464

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    PFIZER CANADA ULC

    U.S.A
    ASPEN
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : ATIVAN

    Dosage Form : TABLET

    Dosage Strength : 0.5MG

    Packaging : 100

    Approval Date :

    Application Number : 2041456

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    PHARMASCIENCE INC

    Canada
    ASPEN
    Not Confirmed
    arrow

    PHARMASCIENCE INC

    Canada
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    LORAZEPAM

    Brand Name : PMS-LORAZEPAM

    Dosage Form : TABLET

    Dosage Strength : 0.5MG

    Packaging : 100/500

    Approval Date :

    Application Number : 728187

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.